Literature DB >> 14600242

An aberrant protein synthesis activity is linked with antibiotic overproduction in rpsL mutants of Streptomyces coelicolor A3(2).

Yoshiko Okamoto-Hosoya1, Takeshi Hosaka1, Kozo Ochi1.   

Abstract

Certain mutations in the rpsL gene (encoding the ribosomal protein S12) activate or enhance antibiotic production in various bacteria. K88E and P91S rpsL mutants of Streptomyces coelicolor A3(2), with an enhanced actinorhodin production, were found to exhibit an aberrant protein synthesis activity. While a high level of this activity (as determined by the incorporation of labelled leucine) was detected at the late stationary phase in the mutants, it decreased with age of the cells in the wild-type strain. In addition, the aberrant protein synthesis was particularly pronounced when cells were subjected to amino acid shift-down, and was independent of their ability to accumulate ppGpp. Ribosomes of K88E and P91S mutants displayed an increased accuracy in protein synthesis as demonstrated by the poly(U)-directed cell-free translation system, but so did K43N, K43T, K43R and K88R mutants, which were streptomycin resistant but showed no effect on actinorhodin production. This eliminates the possibility that the increased accuracy level is a cause of the antibiotic overproduction in the K88E and P91S mutants. The K88E and P91S mutant ribosomes exhibited an increased stability of the 70S complex under low concentrations of magnesium. The authors propose that the aberrant activation of protein synthesis caused by the increased stability of the ribosome is responsible for the remarkable enhancement of antibiotic production in the K88E and P91S mutants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600242     DOI: 10.1099/mic.0.26490-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  25 in total

1.  The novel mutation K87E in ribosomal protein S12 enhances protein synthesis activity during the late growth phase in Escherichia coli.

Authors:  T Hosaka; N Tamehiro; N Chumpolkulwong; C Hori-Takemoto; M Shirouzu; S Yokoyama; K Ochi
Journal:  Mol Genet Genomics       Date:  2004-02-14       Impact factor: 3.291

2.  Antibiotic resistance markers for genetic manipulations of Leptospira spp.

Authors:  Dante Poggi; Priscila Oliveira de Giuseppe; Mathieu Picardeau
Journal:  Appl Environ Microbiol       Date:  2010-05-28       Impact factor: 4.792

3.  Improvement of alpha-amylase production by modulation of ribosomal component protein S12 in Bacillus subtilis 168.

Authors:  Kazuhiko Kurosawa; Takeshi Hosaka; Norimasa Tamehiro; Takashi Inaoka; Kozo Ochi
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

Review 4.  Novel links between antibiotic resistance and antibiotic production.

Authors:  Justin R Nodwell
Journal:  J Bacteriol       Date:  2007-03-23       Impact factor: 3.490

5.  Antibiotic overproduction by rpsL and rsmG mutants of various actinomycetes.

Authors:  Yukinori Tanaka; Mamoru Komatsu; Susumu Okamoto; Shinji Tokuyama; Akira Kaji; Haruo Ikeda; Kozo Ochi
Journal:  Appl Environ Microbiol       Date:  2009-05-15       Impact factor: 4.792

6.  A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.

Authors:  Guojun Wang; Takashi Inaoka; Susumu Okamoto; Kozo Ochi
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

Review 7.  Insights into microbial cryptic gene activation and strain improvement: principle, application and technical aspects.

Authors:  Kozo Ochi
Journal:  J Antibiot (Tokyo)       Date:  2016-07-06       Impact factor: 2.649

8.  The mthA mutation conferring low-level resistance to streptomycin enhances antibiotic production in Bacillus subtilis by increasing the S-adenosylmethionine pool size.

Authors:  Shigeo Tojo; Ji-Yun Kim; Yukinori Tanaka; Takashi Inaoka; Yoshikazu Hiraga; Kozo Ochi
Journal:  J Bacteriol       Date:  2014-02-07       Impact factor: 3.490

9.  Improved bacterial recombineering by parallelized protein discovery.

Authors:  Timothy M Wannier; Akos Nyerges; Helene M Kuchwara; Márton Czikkely; Dávid Balogh; Gabriel T Filsinger; Nathaniel C Borders; Christopher J Gregg; Marc J Lajoie; Xavier Rios; Csaba Pál; George M Church
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-28       Impact factor: 11.205

10.  Identification and characterization of a novel multidrug resistance operon, mdtRP (yusOP), of Bacillus subtilis.

Authors:  Ji-Yun Kim; Takashi Inaoka; Kazutaka Hirooka; Hiroshi Matsuoka; Makiko Murata; Reiko Ohki; Yoshikazu Adachi; Yasutaro Fujita; Kozo Ochi
Journal:  J Bacteriol       Date:  2009-03-13       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.